Send Message
Shaanxi Hongbaiyi Biotech Co., Ltd.
Shaanxi Hongbaiyi Biotech Co., Ltd.
products
Home /

products

EPO Derivative Body Building Peptides Neurological Disease Treatment ARA290

Product Details

Place of Origin: China

Brand Name: Hongbaiyi

Certification: COA, HPLC MR

Model Number: HBY-Cibinetide ARA 290

Payment & Shipping Terms

Minimum Order Quantity: 1KG

Price: Negotiable

Packaging Details: 10mg/vial, 10vials/box

Delivery Time: 3-5 work days after your payment

Payment Terms: Western Union, T/T, MoneyGram

Supply Ability: 4000kg/Month

Get Best Price
Contact Now
Specifications
Highlight:

HPLC Body Building Peptides

,

HPLC EPO Derivative Body Building Peptides

,

HPLC Neurological Disease Treatment ara290 peptide

Product Name:
EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment
CAS No:
1208243-50-8
Outlook:
White Crystalline Powder
Assay:
99%Min
Shelf Life:
2 YEARS
Storage Temperture:
In Cool,dry Place
Molecular Formula:
C51H84N16O21
MW:
1257.307
Product Name:
EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment
CAS No:
1208243-50-8
Outlook:
White Crystalline Powder
Assay:
99%Min
Shelf Life:
2 YEARS
Storage Temperture:
In Cool,dry Place
Molecular Formula:
C51H84N16O21
MW:
1257.307
Description
EPO Derivative Body Building Peptides Neurological Disease Treatment ARA290

What is EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment?

 

Basic Information:

 

Product Name EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment
CAS 1208243-50-8
Purity 99%min
MF

C51H84N16O21

Storage 2-8℃
Deliver Time Within 24 Hours After Receiving The Payment
MOQ 1KG


Brief Introduction:

 

Cibinetide is a first-in-class synthetic peptide designed to activate innate repair mechanisms in the setting of tissue injury as a result of the inflammatory cascade. It selectively binds to the Innate Repair Receptor (IRR) which activates tissue protective, reparative, and anti-inflammatory signaling pathways.

 

Cibinetide lacks erythropoietic effects as it does not activate EPOR homodimers. Correspondingly, unchanged Hb levels have been reported following repeated applications of cibinetide in patients. Thus, cibinetide is not associated with unintended side effects such as thromboembolism secondary to stimulation of erythropoiesis as ascribed for full length recombinant erythropoietin.

 

Product Image:

 

EPO Derivative Body Building Peptides Neurological Disease Treatment ARA290 0EPO Derivative Body Building Peptides Neurological Disease Treatment ARA290 1

 

Application:

 

ARA290 is commonly used in clinical trials to treat neurological diseases.

 

Function:

 

It was proved that ARA290 is good for myocardial infarction, dilated cardiomyopathy, experimental ischemic stroke, peripheral nerve trauma and wound healing.

 

Package and Shipping of EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment

 

EPO Derivative Body Building Peptides Neurological Disease Treatment ARA290 2

 

Shipping:

 

With 3-5 work days after your payment

 

FAQ of EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment

 

Q1: Do you Accept Sample Order?

A: Yes. The smallest order we accept is 1 BOX.

 

Q2: Do you accept VISA business credit card?

A: Yes. VISA business credit card is in our payment .

 

Q3: Is there any discount?
A: Yes, if you want to purchase larger quantity, we can offer better price for you.

 

Q4: How long does it take to me if I order?

A: About 3-5 days upon recepient of payment.

 

Q5: What kind of transportation do you have?

A: We have many ways of transportations, eg: Air, Sea, Special Lines,TNT, FEDEX, EMS, ect.

 

Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send